Leaving Community
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cap Manufacturers Model Name
Description: Manufacturer's designation of the EEG cap model (e.g., M10)
Preferred ID: ILX:0739350 Type: term ID# ILX:0739350 Score: 0
Accessory nucleus
Description: Nucleus in the cervical spinal cord containing motor neurons that innervate the sternocleidomastoid and trapezius muscles in the human via nerve fibers that travel through the 11th cranial nerve (Heimer, The human brain and spinal cord, 2nd ed, 1995, pg 260)
Preferred ID: MESH:M0593051 Type: term ID# ILX:0100216 Score: 0
Nucleus raphe magnus
Description: The nucleus raphe magnus, located directly rostral to the raphe obscurus, is afferently stimulated from axons in the spinal cord and cerebellum. This makes the magnus a likely candidate for part of the motor system; however, it seems to participate in the endogenous analgesia system. The magnus receives descending afferents from the periaqueductal gray, the paraventricular hypothalamic nucleus, central nucleus of the amygdala, lateral hypothalamic area, parvocellular reticular nucleus and the prelimbic, infralimbic, medial and lateral precentral cortices . All of these brain areas influence the main function of the raphe magnus. The main function of the magnus is mostly pain mediation; in fact it sends projections to the dorsal horn of the spinal cord to directly inhibit pain. The periaquiductal gray, the epicenter of analgesia, sends efferent connections to the nucleus raphe magnus in when it is stimulated by opiates (endogenous or otherwise). Electrical stimulation of the PAG produces analgesia, as well as administration of morphine to the PAG or n.r. magnus. The antinociceptic effects of electrical stimulation of the PAG can be blocked by administering naloxone, an opiate antagonist, to the n.r. magnus. All of this seems to indicate that the magnus is part of the endogenous opiate system, and acts to inhibit pain in the spinal cord. [WP,unvetted].
Preferred ID: MESH:M0591381 Type: term ID# ILX:0107791 Score: 0
Nucleus raphe obscurus
Description: The raphe obscurus projects to the cerebellar lobes VI and VII and to crus II along with the nucleus raphe pontis . This so called obscure nucleus has also been implicated in the modulation of the hypoglossal nerve. It has been observed that the ablation of this nucleus causes a change in the firing pattern in the XII nerve . In addition, the raphe obscurus mediates expiration via the inhibitory effect of serotonin and depresses periodic synaptic potentials . It has also been shown that this nucleus stimulates gastrointestinal motor function; microinjections of 5-HT into the n.r. obscurus increase gastric movement . [WP,unvetted].
Preferred ID: MESH:M0591393 Type: term ID# ILX:0107793 Score: 0
Dog
Description: A mammal of the carnivora order and genus canis.
Preferred ID: NCBITaxon:9615 Type: term ID# ILX:0103377 Score: 0
11-dehydro-thromboxane B2
Description:
Preferred ID: NIFEXT:5182 Type: term ID# ILX:0100005 Score: 0
Acetohexamide
Description: A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide. (PubChem) Pharmacology: Acetohexamide is an intermediate-acting, first-generation oral sulfonylurea. It lowers blood sugar by stimulating the pancreatic beta cells to secrete insulin and by helping the body use insulin efficiently. The pancreas must produce insulin for this medication to work. Acetohexamide has one-third the potency of chlorpropamide, and twice the potency of tolbutamide; however, similar hypoglycemic efficacy occurs with equipotent dosage of sulfonylureas. Mechanism of action: Sulfonylureas such as acetohexamide bind to an ATP-dependent K+ channel on the cell membrane of pancreatic beta cells. This inhibits a tonic, hyperpolarizing outflux of potassium, which causes the electric potential over the membrane to become more positive. This depolarization opens voltage-gated Ca2+ channels. The rise in intracellular calcium leads to increased fusion of insulin granulae with the cell membrane, and therefore increased secretion of (pro)insulin. Drug type: Approved. Small Molecule. Drug category: Hypoglycemic Agents. Sulfonylureas
Preferred ID: CHEBI:28052 Type: term ID# ILX:0100236 Score: 0
Accumbens nucleus core nucleus neuron
Description:
Preferred ID: NLX:151892 Type: term ID# ILX:0100224 Score: 0
Accessory olfactory bulb glomerular layer of ABA 2009
Description:
Preferred ID: NLX:153574 Type: term ID# ILX:0100218 Score: 0
Accessory facial nucleus of PHT00
Description:
Preferred ID: ILX:0100213 Type: term ID# ILX:0100213 Score: 0
Accelleration stimulus transduction
Description: The series of events involved in equilibrioception in which a sensory mechanical stimulus is received by a cell and converted into a molecular signal. During equilibrioception, mechanical stimuli may be in the form of input from pressure receptors or from the labyrinth system of the inner ears.
Preferred ID: ILX:0100203 Type: term ID# ILX:0100203 Score: 0
Academic Free License
Description: An open source license, identical to Open Source License (OSL) 3.0 except for the reciprocal source code obligation: Under AFL 3.0, Derivative Works of AFL 3.0-licensed Original Works can be licensed under other licenses, and the Source Code of those Derivative Works need not be disclosed. In effect, then, AFL 3.0 is like the BSD license, with no reciprocal obligation to disclose source code. AFL 3.0 differs materially from OSL 3.0 only in that important underlined half-sentence in § 1(c), which now authorizes distribution "under any license of your choice that does not contradict the terms and conditions, including Licensor's reserved rights and remedies, in this Academic Free License." In all other material respects, AFL 3.0 uses all the same definitions and, except for reciprocity, can be interpreted the same way as OSL 3.0.
Preferred ID: NLX:152785 Type: term ID# ILX:0100193 Score: 0
Acetate
Description:
Preferred ID: NIFEXT:5232 Type: term ID# ILX:0100233 Score: 0
Action potential characteristic
Description:
Preferred ID: NLX:152523 Type: term ID# ILX:0100283 Score: 0
Activated
Description: Microglial activation, e.g., in brain injury, is characterized by enlargement, changes in shape, and increased synthesis of cytokines such as IL-1. There are three subtypes: primed, enlarged, phagocytic
Preferred ID: SAO:5413665309 Type: term ID# ILX:0100285 Score: 0
Adalimumab
Description: Anti-TNF antibody, expressed in mammalian cell culture, 1330 residues, MW
Preferred ID: ILX:0100305 Type: term ID# ILX:0100305 Score: 0
Adamantinous Craniopharyngioma
Description: The adamantinous form presents in children and adolescents as an expanding cystic lesion in the pituitary region. The cystic cavity is filled with a black viscous substance and histologically the tumor is composed of adamantinomatous epithelium and areas of calcification and necrosis. Papillary craniopharyngiomas occur in adults, and histologically feature a squamous epithelium with papillations (MeSH).
Preferred ID: ILX:0100306 Type: term ID# ILX:0100306 Score: 0
Actual Human Performers Sequence
Description: The list of current human performers that are actually involved or responsible for performing the Workitem. Zero or more items may be included in this sequence. Note: Initially this list will be empty.
Preferred ID: DICOM:0040_4035 Type: term ID# ILX:0100295 Score: 0
Acute Disseminated Encephalomyelitis
Description: An acute or subacute inflammatory process of the CENTRAL NERVOUS SYSTEM characterized histologically by multiple foci of perivascular demyelination. Symptom onset usually occurs several days after an acute viral infection or immunization, but it may coincide with the onset of infection or rarely no antecedent event can be identified. Clinical manifestations include CONFUSION, somnolence, FEVER, nuchal rigidity, and involuntary movements. The illness may progress to COMA and eventually be fatal (MeSH).
Preferred ID: ILX:0100301 Type: term ID# ILX:0100301 Score: 0
Adaxial to
Description: A relational or spatial quality in which the bearer entity is located on the side nearest to the axis of an organ or organism.
Preferred ID: ILX:0100309 Type: term ID# ILX:0100309 Score: 0
About
Welcome to the Neuroscience Information Framework Project, designed to serve the biomedical research community. NIF maintains the largest searchable collection of neuroscience data, the largest catalog of biomedical resources, and the largest ontology for neuroscience on the web. We welcome all feedback and suggestions and are actively looking for resource providers to make their resources accessible through NIF. Learn about the tools available to help you share your data and discover a dynamic inventory of Web-based neuroscience resources.
Contact Us
